{"id":325584,"date":"2026-10-23T16:15:31","date_gmt":"2026-10-23T10:45:31","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=325584"},"modified":"2026-10-23T16:15:31","modified_gmt":"2026-10-23T10:45:31","slug":"midcap-quality-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap Quality Stocks to Watch for Future Multibagger Potential: Mazagon Dock, Ajanta Pharma, 3M India and CRISIL"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Mazagon Dock Rs 1,922.30. Ajanta Pharma Rs 3,298.90. 3M India Rs 30,115. CRISIL Rs 4,527.40. Market caps from Rs 32,794 crore to Rs 84,823 crore. Data as of 22 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Mazagon Dock, Ajanta Pharma, 3M India and CRISIL are the 4 picks in this quality stocks watchlist, with market caps between Rs 32,794 crore and Rs 84,823 crore. Mazagon Dock stands out for the fastest profit growth, 44.01% a year since FY22, while Ajanta Pharma offers the strongest latest-quarter profit growth at 30.89%. PE ratios run from 29.72 to 59.71, so compare each one with its industry PE before investing. All figures are as of 22 October 2026.<\/p>\n<\/p><\/div>\n<p>Quality stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Mazagon Dock, Ajanta Pharma, 3M India and CRISIL meet that test, with market caps from Rs 32,794 crore to Rs 84,823 crore and Mazagon Dock offering the fastest profit growth, 44.01% a year since FY22. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a return on equity above 18 per cent, an operating margin above 15 per cent and a debt-to-equity ratio below 0.5, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a return on equity above 18 per cent, an operating margin above 15 per cent and a debt-to-equity ratio below 0.5, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening quality stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 22 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quality-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#What_Are_Quality_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Quality Stocks and Why Do They Attract Multibagger Interest?\">What Are Quality Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Quality_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Quality Stocks at a Glance: Price, Market Cap, PE and ROE\">Quality Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Mazagon_Dock_4401_Profit_CAGR_Since_FY22\" title=\"Mazagon Dock: 44.01% Profit CAGR Since FY22\">Mazagon Dock: 44.01% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Ajanta_Pharma_Return_on_Equity_of_2333\" title=\"Ajanta Pharma: Return on Equity of 23.33%\">Ajanta Pharma: Return on Equity of 23.33%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#3M_India_Return_on_Equity_of_2954\" title=\"3M India: Return on Equity of 29.54%\">3M India: Return on Equity of 29.54%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#CRISIL_Return_on_Equity_of_2703\" title=\"CRISIL: Return on Equity of 27.03%\">CRISIL: Return on Equity of 27.03%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Quality_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Quality Stocks: Financial Comparison on Growth and Margins\">Quality Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Mazagon_Dock_Ajanta_Pharma_3M_India_and_CRISIL\" title=\"Institutional Holding in Mazagon Dock, Ajanta Pharma, 3M India and CRISIL\">Institutional Holding in Mazagon Dock, Ajanta Pharma, 3M India and CRISIL<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Quality_Stocks\" title=\"Risks to Weigh in Quality Stocks\">Risks to Weigh in Quality Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Quality_Stocks\" title=\"How to Choose Between Quality Stocks\">How to Choose Between Quality Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Quality_Stocks_to_Watch\" title=\"Frequently Asked Questions on Quality Stocks to Watch\">Frequently Asked Questions on Quality Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Which_are_the_best_quality_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best quality stocks to watch for multibagger potential?\">Which are the best quality stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Is_3M_India_a_good_stock_for_long-term_investors\" title=\"Is 3M India a good stock for long-term investors?\">Is 3M India a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Can_Mazagon_Dock_become_a_multibagger_from_here\" title=\"Can Mazagon Dock become a multibagger from here?\">Can Mazagon Dock become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Mazagon_Dock_Ajanta_Pharma_3M_India_and_CRISIL\" title=\"What is the market cap of Mazagon Dock, Ajanta Pharma, 3M India and CRISIL?\">What is the market cap of Mazagon Dock, Ajanta Pharma, 3M India and CRISIL?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_quality_stocks\" title=\"What are the risks of investing in quality stocks?\">What are the risks of investing in quality stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#Why_is_3M_India_trading_at_a_PE_of_5971\" title=\"Why is 3M India trading at a PE of 59.71?\">Why is 3M India trading at a PE of 59.71?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/midcap-quality-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Mazagon_Dock_Ajanta_Pharma_3M_India_and_CRISIL\" title=\"How much do institutions hold in Mazagon Dock, Ajanta Pharma, 3M India and CRISIL?\">How much do institutions hold in Mazagon Dock, Ajanta Pharma, 3M India and CRISIL?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Quality_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Quality Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Quality stocks are shares of mid sized companies that earn high returns, keep healthy margins and borrow little. The four here cover shipbuilding, pharmaceuticals, industrial products and credit ratings.<\/p>\n<p>Returns, margins and a light balance sheet together define a quality business. For quality stocks, rising profit adds to the case. With quality stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for quality stocks are complete. Read each company&#8217;s latest results and exchange filings before acting on quality stocks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Quality_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Quality Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 22 October 2026. Mazagon Dock has the lowest PE of the group at 29.72, while 3M India posts the highest return on equity at 29.54%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/mazdock\/mazagon-dock-shipbuilders-ltd-share-price-today\">Mazagon Dock Shipbuilders<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,922.30<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">84,823<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.72<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">48.92<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.48%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.05<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,922.30 to 2,881.80<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,298.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">41,525<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.59<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.35<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.33%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,380.20 to 3,796.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/3mindia\/3m-india-ltd-share-price-today\">3M India<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30,115<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34,492<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">59.71<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.79<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.54%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">28,730.00 to 38,030.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/crisil\/crisil-ltd-share-price-today\">CRISIL<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,527.40<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32,794<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.08<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">33.26<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.03%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,686.00 to 5,064.90<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Mazagon_Dock_4401_Profit_CAGR_Since_FY22\"><\/span><strong>Mazagon Dock: 44.01% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mazagon Dock Shipbuilders builds warships and submarines for the Indian Navy and is a key defence shipyard. It reported FY26 revenue of Rs 14,145.71 crore, up 12.77% year on year, and net profit of Rs 2,421.88 crore, up 6.35%. Net profit has compounded at 44.01% a year since FY22, while revenue has grown 23.18% a year. Operating margin was 26.20% in FY26. The debt-to-equity ratio is 0.05, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 10.40% to Rs 3,255.88 crore and net profit grew 22.12% to Rs 512.04 crore. The share price has gained 1461.53% over five years. Promoters hold 81.22%, which keeps ownership stable. The stock trades at a PE of 29.72 against an industry PE of 48.92, below the sector average, with a return on equity of 26.48%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ajanta_Pharma_Return_on_Equity_of_2333\"><\/span><strong>Ajanta Pharma: Return on Equity of 23.33%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 36.59 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"3M_India_Return_on_Equity_of_2954\"><\/span><strong>3M India: Return on Equity of 29.54%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>3M India sells industrial, safety, healthcare, electronics and consumer products and is part of the global 3M group. It reported FY24 revenue of Rs 4,267.65 crore, up 5.96% year on year, and net profit of Rs 583.42 crore, up 29.36%. Net profit has compounded at 16.00% a year since FY20, while revenue has grown 8.92% a year. Operating margin was 19.99% in FY24. The debt-to-equity ratio is 0.10, which keeps interest costs low.<\/p>\n<p>In the June 2024 quarter, revenue rose 0.33% to Rs 1,068.33 crore and net profit grew 21.62% to Rs 157.15 crore. Promoters hold 75.00%, which keeps ownership stable. The stock trades at a PE of 59.71 against an industry PE of 23.79, with a return on equity of 29.54%. The dividend yield is 1.65%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CRISIL_Return_on_Equity_of_2703\"><\/span><strong>CRISIL: Return on Equity of 27.03%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>CRISIL is a leading credit rating and analytics company, majority-owned by S&amp;P Global, that also offers research, risk solutions and data services. It reported CY25 revenue of Rs 3,755.55 crore, up 12.13% year on year, and net profit of Rs 766.01 crore, up 11.98%. Net profit has compounded at 13.24% a year since CY21, while revenue has grown 12.11% a year. Operating margin was 32.66% in CY25. The debt-to-equity ratio is 0.10, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 37.08 against an industry PE of 33.26, with a return on equity of 27.03%. In the June 2026 quarter, revenue rose 26.54% to Rs 1,096.53 crore and net profit grew 26.16% to Rs 216.46 crore. Domestic institutions raised their holding from 12.07% in June 2025 to 12.95% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Quality_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Quality Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these quality stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Mazagon Dock<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14,145.71<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,421.88<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.77%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.18%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44.01%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Ajanta Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,624.93<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,056<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.60%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.94%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.33%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3M India<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,267.65<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">583.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.92%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.00%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.71%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">CRISIL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,755.55 (CY25)<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">766.01 (CY25)<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.13%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.11%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.24%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30.59%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these quality stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Mazagon_Dock_Ajanta_Pharma_3M_India_and_CRISIL\"><\/span><strong>Institutional Holding in Mazagon Dock, Ajanta Pharma, 3M India and CRISIL<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these quality stocks alongside the promoter. The table uses the latest reported quarter for each. Ajanta Pharma has the deepest institutional backing, with FII and DII together holding 29.57% as of September 2026. Domestic institutions increased their holding over the past year in Ajanta Pharma (from 17.90% to 21.94%) and CRISIL (from 12.07% to 12.95%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Mazagon Dock<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">81.22%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1.72%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.01%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.04%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Ajanta Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">63.47%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.63%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.94%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3M India<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">75.00%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.99%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">CRISIL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">66.64%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.95%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.03%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Quality_Stocks\"><\/span><strong>Risks to Weigh in Quality Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with quality stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> 3M India trades at a PE of 59.71 against an industry PE of 23.79, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Quality_Stocks\"><\/span><strong>How to Choose Between Quality Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from quality stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (23.79 to 48.92) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Mazagon Dock, Ajanta Pharma, 3M India and CRISIL live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among quality stocks, Mazagon Dock stands out for the fastest profit growth, 44.01% a year since FY22, Ajanta Pharma for the strongest latest-quarter profit growth at 30.89%, 3M India for the highest return on equity at 29.54% and CRISIL for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.10. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing quality stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Quality_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Quality Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_quality_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best quality stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mazagon Dock, Ajanta Pharma, 3M India and CRISIL are the 4 names this list highlights, with market caps of Rs 84,823 crore, Rs 41,525 crore, Rs 34,492 crore and Rs 32,794 crore respectively. Mazagon Dock is notable for the fastest profit growth, 44.01% a year since FY22. Ajanta Pharma stands out for the strongest latest-quarter profit growth at 30.89%. 3M India offers the highest return on equity at 29.54%. CRISIL brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.10. These are watchlist names for quality stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_3M_India_a_good_stock_for_long-term_investors\"><\/span><strong>Is 3M India a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> 3M India has a return on equity of 29.54%, a PE of 59.71 against an industry PE of 23.79 and a market cap of Rs 34,492 crore. Net profit has compounded at 16.00% a year since FY20, and FY24 revenue rose 5.96% while June 2024 quarter net profit grew 21.62%. Long-term returns in quality stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Mazagon_Dock_become_a_multibagger_from_here\"><\/span><strong>Can Mazagon Dock become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mazagon Dock has already gained 1461.53% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in quality stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 44.01% a year since FY22, and FY26 revenue rose 12.77%. At a PE of 29.72 against an industry PE of 48.92, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Mazagon_Dock_Ajanta_Pharma_3M_India_and_CRISIL\"><\/span><strong>What is the market cap of Mazagon Dock, Ajanta Pharma, 3M India and CRISIL?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 22 October 2026, Mazagon Dock has a market cap of Rs 84,823 crore, Ajanta Pharma has a market cap of Rs 41,525 crore, 3M India has a market cap of Rs 34,492 crore and CRISIL has a market cap of Rs 32,794 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on quality stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_quality_stocks\"><\/span><strong>What are the risks of investing in quality stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. 3M India trades at a PE of 59.71 against an industry PE of 23.79, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_3M_India_trading_at_a_PE_of_5971\"><\/span><strong>Why is 3M India trading at a PE of 59.71?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> 3M India&#8217;s PE of 59.71 compares with an industry PE of 23.79. The market is paying a premium for a return on equity of 29.54%, profit growth of 16.00% a year since FY20 and latest-quarter profit growth of 21.62%, which also means the stock is more sensitive if growth slows. Investors in quality stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Mazagon_Dock_Ajanta_Pharma_3M_India_and_CRISIL\"><\/span><strong>How much do institutions hold in Mazagon Dock, Ajanta Pharma, 3M India and CRISIL?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 6.73% of Mazagon Dock (1.72% and 5.01%), 29.57% of Ajanta Pharma (7.63% and 21.94%), 11.68% of 3M India (3.69% and 7.99%) and 19.33% of CRISIL (6.38% and 12.95%). Rising institutional holding is a useful signal in quality stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best quality stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mazagon Dock, Ajanta Pharma, 3M India and CRISIL are the 4 names this list highlights, with market caps of Rs 84,823 crore, Rs 41,525 crore, Rs 34,492 crore and Rs 32,794 crore respectively. Mazagon Dock is notable for the fastest profit growth, 44.01% a year since FY22. Ajanta Pharma stands out for the strongest latest-quarter profit growth at 30.89%. 3M India offers the highest return on equity at 29.54%. CRISIL brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.10. These are watchlist names for quality stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is 3M India a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"3M India has a return on equity of 29.54%, a PE of 59.71 against an industry PE of 23.79 and a market cap of Rs 34,492 crore. Net profit has compounded at 16.00% a year since FY20, and FY24 revenue rose 5.96% while June 2024 quarter net profit grew 21.62%. Long-term returns in quality stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Mazagon Dock become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mazagon Dock has already gained 1461.53% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in quality stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 44.01% a year since FY22, and FY26 revenue rose 12.77%. At a PE of 29.72 against an industry PE of 48.92, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Mazagon Dock, Ajanta Pharma, 3M India and CRISIL?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 22 October 2026, Mazagon Dock has a market cap of Rs 84,823 crore, Ajanta Pharma has a market cap of Rs 41,525 crore, 3M India has a market cap of Rs 34,492 crore and CRISIL has a market cap of Rs 32,794 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on quality stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in quality stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. 3M India trades at a PE of 59.71 against an industry PE of 23.79, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is 3M India trading at a PE of 59.71?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"3M India's PE of 59.71 compares with an industry PE of 23.79. The market is paying a premium for a return on equity of 29.54%, profit growth of 16.00% a year since FY20 and latest-quarter profit growth of 21.62%, which also means the stock is more sensitive if growth slows. Investors in quality stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Mazagon Dock, Ajanta Pharma, 3M India and CRISIL?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 6.73% of Mazagon Dock (1.72% and 5.01%), 29.57% of Ajanta Pharma (7.63% and 21.94%), 11.68% of 3M India (3.69% and 7.99%) and 19.33% of CRISIL (6.38% and 12.95%). Rising institutional holding is a useful signal in quality stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 midcap quality stocks compared on market cap, PE, ROE, growth and institutional holding: Mazagon Dock, Ajanta Pharma, 3M India and CRISIL.<\/p>\n","protected":false},"author":33,"featured_media":325583,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[15071,15070],"class_list":["post-325584","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-quality-sector","tag-quality-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["325583"],"rank_math_title":["Quality Stocks 2026: Mazagon Dock, Ajanta Pharma"],"rank_math_description":["Quality stocks to watch for multibagger potential: Mazagon Dock, Ajanta Pharma, 3M India and CRISIL. Compare market cap, PE, ROE, growth and institutional holding."],"rank_math_focus_keyword":["quality stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-midcap-quality-stocks-to-watch-for-future-multibagger-potential-mazagon-dock.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/325584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=325584"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/325584\/revisions"}],"predecessor-version":[{"id":325585,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/325584\/revisions\/325585"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/325583"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=325584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=325584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=325584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}